27666910 — 64764-0300-20 Vedolizumab 300 Mg Powder-inj [cvh]
$25,609
All-payer median here
$19,656
Cash / self-pay here
9
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.